PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 2, 2026JCEM Case Reports0 citationsOpen Access

Noninsulinoma Hyperinsulinemic Hypoglycemia Syndrome Emerging Post-Nissen Fundoplication

View Full Paper
JRJean Carlos Ramos-CardonaMRMemona RafiqSMSuzanne Martinez

Key Points

  • To differentiate between insulinoma and noninsulinoma hyperinsulinemic hypoglycemia in a patient with a Nissen fundoplication history.
  • Detailed case evaluation of a 54-year-old male patient
  • Continuous glucose monitoring (CGM) to assess glucose levels
  • Diagnostic tests to exclude insulinoma
  • Treatment with diazoxide to manage hypoglycemic episodes
  • Confirmed inappropriate endogenous insulin secretion in the absence of insulinoma
  • Successful reduction in frequency and severity of hypoglycemic events with diazoxide
  • Improved quality of life following management intervention

Abstract

Abstract Hypoglycemia presents a rare and complex diagnostic challenge, particularly in individuals with a history of upper gastrointestinal procedures such as Nissen fundoplication. Given the overlapping clinical presentations, it is essential to distinguish between insulinoma and noninsulinoma hyperinsulinemic hypoglycemia syndrome. In this report, we outline the case of a 54-year-old man with a history of Nissen fundoplication who presented with recurrent, severe hypoglycemic episodes, often occurring without warning, and significantly impairing his quality of life. Continuous glucose monitoring (CGM) revealed frequent hypoglycemia in both the postprandial and fasting states. Diagnostic evaluation excluded insulinoma but confirmed inappropriate endogenous insulin secretion, consistent with nesidioblastosis. The patient was successfully managed with diazoxide, which significantly reduced the frequency and severity of hypoglycemic events. This case underscores the importance of considering endogenous hyperinsulinemia in postfundoplication patients with unexplained hypoglycemia. It also highlights the utility of CGM and pharmacologic therapy in improving safety, enabling individualized care, and reducing the risk of hypoglycemia unawareness and its associated complications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ramos-Cardona et al. (2025) studied this question.

synapsesocial.com/papers/6980fd60c1c9540dea80f173https://doi.org/10.1210/jcemcr/luaf326
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Noninsulinoma Pancreatogenous Hypoglycemia: A Novel Syndrome of Hyperinsulinemic Hypoglycemia in Adults Independent of Mutations in Kir6.2 and SUR1 Genes 11999 · 195 citations
  2. 2Adult focal β-cell nesidioblastosis: A case report2023 · 2 citations
  3. 3Adult-Onset Focal Nesidioblastosis With Nodular Formation Mimicking Insulinoma2021 · 20 citations
  4. 4Pancreatic Nesidioblastosis in Adults1989 · 50 citations
  5. 5A puzzling Case of Profound Hypoglycemia: Nesidioblastosis2024 · 1 citations